The CD55 antigen is a single chain glycosyl-phosphatidyl-inositol (GPI)-anchored, cell surface protein. This molecule undergoes post-transcriptional and post-translational modification resulting in a heterogeneous molecular weight ranging from 55 to 80 kDa. The CD55 antigen, also named Decay Accelerating Factor (DAF) is involved in the regulation of both alternative and classical complement pathways. C3b/C3Bb and C4b/C4b2a convertases, as well as echovirus, coxsackie B virus and CD97 are reported to interact with CD55. Like other GPI-anchored proteins, CD55 is associated in the cytoplasmic compartment with tyrosine kinases allowing signal transduction. The CD55 molecule is widely expressed on human cells including leucocytes, erythrocytes and platelets. CD55 is weakly expressed on NK cells.

Specifications

Specificity CD55
Form PE
Clone JS11KSC2.3
Flow Product Line IOTest
Isotype IgG1 Mouse
Format Liquid
Size 100 Tests
Regulatory Status CE
Target Species Human
Other Names CD55, DAF, Decay Accelerating Factor
UNSPSC 41116015

NOT ALL PRODUCTS ARE AVAILABLE IN ALL COUNTRIES
PRODUCT AVAILABILITY AND REGULATORY STATUS DEPENDS ON COUNTRY REGISTRATION PER APPLICABLE REGULATIONS

The listed regulatory status for products correspond to one of the below:
IVD: In Vitro Diagnostic Products. These products are labeled "For In Vitro Diagnostic Use."
ASR: Analyte Specific Reagents. These reagents are labeled "Analyte Specific Reagents. Analytical and performance characteristics are not established."
CE: Products intended for in vitro diagnostic use and conforming to European Directive (98/79/EC). (Note: Devices may be CE marked to other directives than (98/79/EC)
RUO: Research Use Only. These products are labeled "For Research Use Only. Not for use in diagnostic procedures."
LUO: Laboratory Use Only. These products are labeled "For Laboratory Use Only."
No Regulatory Status: Non-Medical Device or non-regulated articles. Not for use in diagnostic or therapeutic procedures.